Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Jiangsu Deyuan Pharmaceutical Co Net Margin %?
Jiangsu Deyuan Pharmaceutical CoBJSE:920735 97 Net Margin % is 24.12% as of Jun. 2026, which is 54% above its 10-year median of 15.65. GuruFocus rates BJSE:920735 with a GF Score™ of 97/100 and a GF Value™ of ¥29.61 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 960 Drug Manufacturers companies, Jiangsu Deyuan Pharmaceutical Co ranks better than 90.83% on this metric.
The historical rank and industry rank for Jiangsu Deyuan Pharmaceutical Co's Net Margin % or its related term are showing as below:
BJSE:920735'
s Net Margin % Range Over the Past 10 Years
Min: 13.9 Med: 15.65 Max: 23.69
Current: 23.69
BJSE:920735's Net Margin % is ranked better than 90.83% of 960
companies
in the Drug Manufacturers industry
Industry Median: 5.205
vs BJSE:920735: 23.69
Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Jiangsu Deyuan Pharmaceutical Co Net Margin % Related Terms
Jiangsu Deyuan Pharmaceutical Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Deyuan Pharmaceutical Co Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Deyuan Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Deyuan Pharmaceutical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Deyuan Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Jiangsu Deyuan Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) has a Net Margin % of 24.12% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Jiangsu Deyuan Pharmaceutical Co and its competitors. This is 54% above median its historical median of 15.65. Over the past decade, Jiangsu Deyuan Pharmaceutical Co's Net Margin % has ranged from 13.90 to 23.69. According to the industry distribution chart, Jiangsu Deyuan Pharmaceutical Co ranks #88 out of 960 companies in the Drug Manufacturers industry, placing it in the top 9.2%.
Is Jiangsu Deyuan Pharmaceutical Co's Net Margin % too high?
Jiangsu Deyuan Pharmaceutical Co's current Net Margin % of 24.12% is 54% above median its 10-year median of 15.65. Over the past 10 years, this metric has ranged from a low of 13.90 to a high of 23.69. The Drug Manufacturers industry median Net Margin % is 5.21. Jiangsu Deyuan Pharmaceutical Co's value of 24.12% is 363.4% above this industry median. Based on the distribution chart, Jiangsu Deyuan Pharmaceutical Co ranks #88 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Deyuan Pharmaceutical Co has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Deyuan Pharmaceutical Co's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jiangsu Deyuan Pharmaceutical Co ranks #88 out of 960 companies for Net Margin %. This places Jiangsu Deyuan Pharmaceutical Co in the top 9% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.21. Jiangsu Deyuan Pharmaceutical Co's value of 24.12% is 363.4% above this benchmark. Historically, Jiangsu Deyuan Pharmaceutical Co's own Net Margin % has ranged from 13.90 to 23.69 over the past decade. While the company's 10-year median is 15.65 vs. the industry median of 5.21, Jiangsu Deyuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.21, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Deyuan Pharmaceutical Co's current Net Margin % of 24.12% is 363.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Jiangsu Deyuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Deyuan Pharmaceutical Co's current Net Margin % is 24.12%, which is 54% above median its own 10-year median of 15.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Deyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.61, compared to a current price of ¥26.66 — trading 10% below its estimated fair value. The current Net Margin % is 24.12%, which is 54% above median its 10-year median of 15.65 and 363.4% above the Drug Manufacturers industry median of 5.21. Jiangsu Deyuan Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Jiangsu Deyuan Pharmaceutical Co (BJSE:920735), the current Net Margin % is 24.12% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥26.66 is trading 10% below its estimated GF Value™ of ¥29.61.
GuruFocus considers Jiangsu Deyuan Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for BJSE:920735:
Net Margin %: 24.12% (54% above median its 10-year median of 15.65)
GF Value™: ¥29.61 vs. price of ¥26.66 (10% below fair value)
Industry Position: 363.4% above the Drug Manufacturers median (#88 of 960)
No single metric tells the full story. See the BJSE:920735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920735 has been successfully added to your 
